| Oct 5 |
Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Path To Profitability
|
| Oct 1 |
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
| Sep 5 |
Akebia Therapeutics and U.S. Renal Care Initiate the VOICE Trial of Vafseo® (vadadustat) for Patients on Dialysis
|
| Sep 2 |
Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?
|
| Aug 26 |
Here's Why You Should Consider Buying Akebia (AKBA) Stock
|
| Aug 19 |
Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia
|
| Aug 16 |
Akebia Therapeutics: Generics Competition Means Rough Weather Ahead
|
| Aug 16 |
5 Small Drug Stocks to Buy as Innovation Reaches Peak
|
| Aug 15 |
Are Medical Stocks Lagging Acrivon Therapeutics, Inc. (ACRV) This Year?
|
| Aug 10 |
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Just Reported And Analysts Have Been Lifting Their Price Targets
|
